Experimental monoclonal antibodies sh ow promise against Epstein-Barr virus

Laden...

2 jaren geleden

Html
Tekst

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Experimental monoclonal antibodies show promise against Epstein-Barr virus 10/27/2022 12:00 PM EDT
Findings highlight viable EBV vaccine targets.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Deel deze op

Laden...

Andere nieuwsbrieven van Niaid.nih.gov

Spotlight on Herbs and Other Botanicals Niaid.nih.gov
5 uren geleden
Find a plan for 2025! There is still time to enroll Niaid.nih.gov
9 uren geleden
HRSA Supports Rural Health Care Niaid.nih.gov
Afgelopen vrijdag om 18:07

Meer nieuwsbrieven van Niaid.nih.gov

Laden...

Experimental monoclonal antibodies sh ow promise against Epstein-Barr virus

Deel deze op

Andere nieuwsbrieven van Niaid.nih.gov

Gerelateerde nieuwsbrieven